StageZero Life Sciences Ltd.
SZLSF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $5 | $1 | $5 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $2 | $2 | $1 |
| Enterprise Value | $7 | $4 | $7 | $6 |
| Revenue | $0 | $0 | $1 | $1 |
| % Growth | 28.1% | -24.9% | -30.3% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -13.9% | 2% | 54.1% | 22.6% |
| EBITDA | -$0 | -$1 | -$0 | -$1 |
| % Margin | -67.4% | -141.7% | -62.7% | -100.2% |
| Net Income | -$0 | -$1 | -$0 | -$1 |
| % Margin | -79.9% | -166.5% | -74% | -110.2% |
| EPS Diluted | -0.003 | -0.005 | -0.003 | -0.007 |
| % Growth | 37.7% | -71% | 53.7% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | -$0 | -$0 | $0 |